While further prospective research is needed to establish the clinical implications and predictive utility for elevated p16 expression in patients with SCD, these initial findings provide molecular evidence of biological aging beginning at a young age in individuals living with SCD. The gene discussed is CDKN2A; the disease is Schnyder corneal dystrophy.